coloxyl
pharmacy retailing (nz) ltd t/a healthcare logistics - bisacodyl 10mg; docusate sodium 100mg; - suppository - active: bisacodyl 10mg docusate sodium 100mg excipient: glycerol estarinum a m.p. 33/35 degrees
dyrax-q tab- bisacodyl, docusate sodium tablet
cho-a pharm.co.,ltd. - bisacodyl 5 mg, docusate sodium 16.75 mg - laxative for temporary relief of occasional constipation and irregularity
coloxyl suppository
aspen pharmacare australia pty ltd - docusate sodium, quantity: 100 mg; bisacodyl, quantity: 10 mg - suppository, moulded - excipient ingredients: macrogol 400; hard fat; propylene glycol - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code) coloxyl suppositories are indicated for constipation and for evacuation of the bowel prior to an operation, or prior to x-ray or physical examination of the colon.
gavilyte-h and bisacodyl- polyethylene glycol 3350, sodium chloride, sodium bicarbonate, potassium chloride and bisacodyl delaye
lupin pharmaceuticals, inc. - bisacodyl (unii: 10x0709y6i) (deacetylbisacodyl - unii:r09078e41y) - bisacodyl 5 mg - gavilyte - h and bisacodyl delayed-release tablet, usp is indicated for cleansing of the colon as a preparation for colonoscopy in adults. the gavilyte - h and bisacodyl delayed-release tablet, usp is contraindicated in the following conditions: - gastrointestinal (gi) obstruction - bowel perforation - toxic colitis and toxic megacolon - gastric retention - ileus pregnancy category c animal reproduction studies have not been conducted. it is not known whether gavilyte - h and bisacodyl delayed-release tablet, usp can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity. gavilyte - h and bisacodyl delayed-release tablet, usp should be given to a pregnant or nursing woman only if clearly needed. it is not known whether this drug is excreted in human milk. because many drugs are excreted in human milk, caution should be exercised when gavilyte - h and bisacodyl delayed-release tablet, usp is administered to a nursing woman. safety and effectiveness in pediatric patients has
dulcolax- bisacodyl tablet, coated
mechanical servants, inc. - bisacodyl (unii: 10x0709y6i) (bisacodyl - unii:10x0709y6i) - bisacodyl 5 mg - stimulant laxative - for temporary relief of occasional constipation and irregularity - this product generally produces bowel movement in 6 to 12 hours
dulcolax- bisacodyl tablet, coated
physicians total care, inc. - bisacodyl (unii: 10x0709y6i) (bisacodyl - unii:10x0709y6i) - bisacodyl 5 mg - - for temporary relief of occasional constipation and irregularity - this product generally produces bowel movement in 6 to 12 hours
bisacodyl- bisacodyl enteric coated tablet, coated
ncs healthcare of ky, inc dba vangard labs - bisacodyl (unii: 10x0709y6i) (bisacodyl - unii:10x0709y6i) - bisacodyl 5 mg - stimulant laxative -relieves occasional constipation and irregularity -this product generally produces bowel movement in 6 to 12 hours
bisacodyl laxative- bisacodyl suppository
medicine shoppe international inc - bisacodyl (unii: 10x0709y6i) (bisacodyl - unii:10x0709y6i) - bisacodyl 10 mg - stimulant laxative - for relief of occasional constipation - this product generally produces bowel movement in 15 minutes to 1 hour
bisacodyl suppository
h and p industries, inc. dba triad group - bisacodyl (unii: 10x0709y6i) (bisacodyl - unii:10x0709y6i) - bisacodyl 10 mg - stimulant laxative - for relief of occasional constipation - this product generally produces bowel movement in 15 minutes to 1 hour
bisacodyl tablet, delayed release
chain drug consortium - bisacodyl (unii: 10x0709y6i) (deacetylbisacodyl - unii:r09078e41y) - bisacodyl 5 mg - stimulant laxative - for relief of occasional constipation and irregularity - this product generally produces bowel movement in 6 to 12 hours